The data have proven that TMPRSS2 is overexpressed in colon adenocarcinoma (COAD), cervical squamous cell carcinoma and endometrial carcinoma (CESC), kidney chromophobe (KICH), prostate adenocarcinoma (PRAD), uterine corpus endometrial carcinoma (UCEC), uterine carcinosarcoma (UCS), and rectal adenocarcinoma (READ). This evidence concerns the gene TMPRSS2 and uterine corpus endometrial carcinoma.